Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Atherosclerosis. 2014 Jan 10;233(1):234–241. doi: 10.1016/j.atherosclerosis.2013.12.043

Figure 4. AAV-mediated overexpression of ApoF in the ApoF knockout mice.

Figure 4

ApoF KO mice were injected with 5 x 1011 genome copies of either an empty AAV vector (Null), or one encoding mouse ApoF (mApoF) under the control of a liver specific promoter. A) Expression of ApoF and Stat2 in the livers of these mice. Expression of C) Ifi27l2a and D) Oas2 in the livers of these animals. Expression of E) Ifi27l2a and F) Oas2 in the spleen (*indicates significant differences at p<0.05 by one way ANOVA followed by Tukey’s post-test).